1st Quarter - Termination
LIEBMAN & ASSOCIATES, INC. for AMYRIS BIOTECHNOLOGIES, INC.
Client
Income
$40,000
Expenses
—
Terminated
Mar 6, 2009
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Energy/Nuclear ENG
Clean and sustainable renewable transportation fuels, jet and diesel, research and development
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBORAH COX | — |
| KARA D'ONOFRIO BYLER | — |
| MURRAY LIEBMAN | — |
| JENNIFER MEHAFFEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.